140 related articles for article (PubMed ID: 31262903)
1. Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
Kim JY; Kim KS; Kim IS; Yoon S
Anticancer Res; 2019 Jul; 39(7):3767-3775. PubMed ID: 31262903
[TBL] [Abstract][Full Text] [Related]
2. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
Kim JY; Park YJ; Lee BM; Yoon S
Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp.
Kim JY; Kim HS; Yoon S
Anticancer Res; 2019 Jul; 39(7):3785-3793. PubMed ID: 31262905
[TBL] [Abstract][Full Text] [Related]
4. P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression.
Cheon JH; Kim JY; Lee BM; Kim HS; Yoon S
Anticancer Res; 2017 Dec; 37(12):6761-6769. PubMed ID: 29187454
[TBL] [Abstract][Full Text] [Related]
5. Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
Kim JY; Son JY; Lee BM; Kim HS; Yoon S
Anticancer Res; 2018 Sep; 38(9):5149-5157. PubMed ID: 30194162
[TBL] [Abstract][Full Text] [Related]
6. P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.
Kim JY; Park Y; Lee BM; Kim HS; Yoon S
Anticancer Res; 2018 Oct; 38(10):5685-5692. PubMed ID: 30275188
[TBL] [Abstract][Full Text] [Related]
7. A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.
Jiang C; Lee SH; Park JH; Lee JS; Park JW; Kim JR; Lee SH; Kim HS; Yoon S
Anticancer Res; 2021 Feb; 41(2):687-697. PubMed ID: 33517273
[TBL] [Abstract][Full Text] [Related]
8. Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells.
Kim JY; Tae IH; Lee BM; Kim HS; Yoon S
Anticancer Res; 2018 Sep; 38(9):5101-5108. PubMed ID: 30194155
[TBL] [Abstract][Full Text] [Related]
9. JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells.
Oh Y; Lee JS; Lee JS; Park JH; Kim HS; Yoon S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562984
[TBL] [Abstract][Full Text] [Related]
10. Sensitization Effects of Repurposed Blood Pressure-regulating Drugs on Drug-resistant Cancer Cells.
Jiang C; Zheng T; Park JH; Lee JS; Oh Y; Kundu A; Kim HS; Yoon S
Anticancer Res; 2021 Dec; 41(12):6179-6190. PubMed ID: 34848472
[TBL] [Abstract][Full Text] [Related]
11. Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.
Lee JS; Oh Y; Park JH; Kyung SY; Kim HS; Yoon S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430288
[TBL] [Abstract][Full Text] [Related]
12. Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance.
Oh Y; Lee JS; Lee JS; Park JH; Kim HS; Yoon S
Anticancer Res; 2022 May; 42(5):2433-2442. PubMed ID: 35489775
[TBL] [Abstract][Full Text] [Related]
13. Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition.
Lim JS; Park Y; Lee BM; Kim HS; Yoon S
Anticancer Res; 2016 Oct; 36(10):5063-5070. PubMed ID: 27798865
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.
Lee JS; Oh Y; Kim HS; Yoon S
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806386
[TBL] [Abstract][Full Text] [Related]
15. Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition.
Choi AR; Jee Jo M; Jung MJ; Sik Kim H; Yoon S
Eur J Pharmacol; 2015 Oct; 764():63-69. PubMed ID: 26134503
[TBL] [Abstract][Full Text] [Related]
16. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.
Cheon JH; Kim KS; Yadav DK; Kim M; Kim HS; Yoon S
Biochem Biophys Res Commun; 2017 Sep; 490(4):1176-1182. PubMed ID: 28669723
[TBL] [Abstract][Full Text] [Related]
17. Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose.
Park Y; Son JY; Lee BM; Kim HS; Yoon S
Anticancer Res; 2017 Aug; 37(8):4139-4146. PubMed ID: 28739698
[TBL] [Abstract][Full Text] [Related]
18. Co-treatment With Aripiprazole and Vincristine Sensitizes P-Glycoprotein-Overexpressing Drug-resistant MCF-7/ADR Breast Cancer Cells.
Shin JK; Kim HS; Yoon S
Anticancer Res; 2024 Mar; 44(3):1051-1062. PubMed ID: 38423668
[TBL] [Abstract][Full Text] [Related]
19. Highly Halaven-resistant KBV20C Cancer Cells Can Be Sensitized by Co-treatment with Fluphenazine.
Cheon JH; Lee BM; Kim HS; Yoon S
Anticancer Res; 2016 Nov; 36(11):5867-5874. PubMed ID: 27793910
[TBL] [Abstract][Full Text] [Related]
20. SP600125 overcomes antimitotic drug-resistance in cancer cells by increasing apoptosis with independence of P-gp inhibition.
Kim JH; Chae M; Choi AR; Sik Kim H; Yoon S
Eur J Pharmacol; 2014 Jan; 723():141-7. PubMed ID: 24333214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
